Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,158
Closed -$2.89M 30
2023
Q4
$2.89M Sell
11,158
-4,977
-31% -$1.22M 0.3% 110
2023
Q3
$4.15M Hold
16,135
0.26% 78
2023
Q2
$4.6M Sell
16,135
-1,177
-7% -$350K 0.46% 68
2023
Q1
$4.67M Buy
17,312
+8,854
+105% +$2.45M 0.48% 68
2022
Q4
$2.34M Hold
8,458
0.42% 60
2022
Q3
$2.26M Buy
8,458
+1,177
+16% +$250K 0.53% 52
2022
Q2
$1.49M Buy
+7,281
New +$1.49M 0.3% 49

Other funds holding BIIB

Power Corp of Canada's BIIB Position: Q1 2024 in Review

Power Corp of Canada sold out of Biogen (BIIB) in Q1 2024, closing a stake of 11,158 shares — an estimated $2.89M sold.

Power Corp of Canada first reported a position in BIIB in Q2 2022 and held it in 7 quarters. The position peaked at $4.67M in Q1 2023. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Power Corp of Canada reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Power Corp of Canada sold 11,158 Biogen shares in Q1 2024, an estimated $2.89M.
  • Power Corp of Canada first reported a position in Biogen in Q2 2022 and held it in 7 quarters.
  • Power Corp of Canada's Biogen position peaked at $4.67M in Q1 2023.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Power Corp of Canada's 13F filing for Q1 2024, filed 14 May 2024.